SAREPTA THERAPEUTICS, INC. Accrued Royalties, Current
SAREPTA THERAPEUTICS, INC. (SRPT) had Accrued Royalties, Current of $10.20 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedRoyaltiesCurrent · last filed 2026-08-05
- 2026-06-30: Accrued Royalties, Current $10.20M.
- 2026-03-31: Accrued Royalties, Current $8.22M.
- 2025-12-31: Accrued Royalties, Current $10.86M.
- 2025-09-30: Accrued Royalties, Current $10.66M.
| Period end | Accrued Royalties, Current |
|---|---|
| 2026-06-30 | $10.20M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $8.22M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $10.86M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $10.66M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $14.00M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $15.66M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $16.63M 10-K · filed 2026-03-02 |
| 2024-09-30 | $12.19M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $7.72M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $11.21M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $12.07M 10-K · filed 2025-02-28 |
| 2023-09-30 | $10.50M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $8.58M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $8.38M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $8.64M 10-K · filed 2024-02-28 |
| 2022-09-30 | $7.86M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $14.75M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $12.98M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $11.96M 10-K · filed 2023-02-28 |
| 2021-09-30 | $11.14M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $9.20M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $8.02M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $7.79M 10-K · filed 2022-03-01 |
| 2020-09-30 | $7.81M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $7.05M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $6.40M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $6.30M 10-K · filed 2021-03-01 |
| 2019-09-30 | $6.35M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $5.82M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $4.46M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $8.25M 10-K · filed 2020-02-26 |
| 2018-09-30 | $4.00M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $3.69M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $3.12M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $2.85M 10-K · filed 2019-02-28 |
| 2017-09-30 | $2.29M 10-Q · filed 2017-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |